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Abstract
We have tested the hypothesis that in vitro exposure of insu-
lin-resistant adipocytes with insulin results in improved insulin
action. A primary culture system of adipocytes from obese
subjects with or without non-insulin-dependent diabetes mel-
litus (NIDDM) and nonobese control subjects has been devel-
oped. The adipocytes when cultured in serum-free medium do
not lose their original characteristics in regard to insulin bind-
ing and glucose transport. The adipocytes from three groups
were incubated with insulin (0, 10-10 M, and lo-7 M) for 24 h
at 370C, receptor-bound insuMin was dissociated, and basal and
insulin (1 X 10-11_10-7 M)-stimulated glucose transport and
"2I-insulin binding were determined. The 24-h insulin expo-
sure of adipocytes from control subjects decreased basal and
insulin-stimulated glucose transport. The effects of 1 X 1o-7M
insulin were more pronounced than 1 X 10-l' M insulin. Simi-
larly, insulin exposure decreased insulin sensitivity and re-
sponsiveness of cultured adipocytes from obese and NIDDM
patients. The insulin-induced reduction in insulin sensitivity
and responsiveness for glucose transport in three groups were
due to alterations at insulin binding and postbinding levels. In
conclusion, insulin induces insulin resistance in control adipo-
cytes and further worsens the insulin resistance of adipocytes
from obese and NIDDM subjects. For insulin to improve the
insulin resistance of adipocytes from NIDDM patients, either
more prolonged in vitro insulin exposure and/or other hor-
monal factors might be required.
Introduction
Insulin resistance in obesity and non-insulin-dependent dia-
betes mellitus (NIDDM)' is characterized at the cellular level
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1. Abbreviations used in this paper: GTT, glucose tolerance test; KRB,
Kreb's-Ringer bicarbonate; NIDDM, non-insulin-dependent diabetes
mellitus; obese NGTT, morbidly obese subjects with normal GTT;
obese NIDDM, morbidly obese patients with NIDDM.
by both binding and postbinding defects. The overall insulin
resistance in NIDDM, with or without obesity, has been well
demonstrated with the use of several in vivo techniques ( 1-6).
Insulin therapy ofNIDDM subjects improves insulin sensitiv-
ity and responsiveness of peripheral glucose utilization as as-
sessed by glucose clamp techniques (7-9). Several ofthe abnor-
malities of carbohydrate and lipid metabolism in isolated adi-
pocytes from NIDDM patients have also been shown to
improve with insulin treatment (10, 1 1). These in vivo and in
vitro studies suggest that insulin improves the insulin sensitiv-
ity and responsiveness ofperipheral tissues. Enhanced insulin-
stimulated glucose transport with decreased or unaltered sensi-
tivity have also been reported in isolated adipocytes from ex-
perimentally induced chronic hyperinsulinemic rats (12-14)
or hyperinsulinemic young obese Zucker rats (15, 16). Thus, it
is likely that insulin sensitizes the insulin-resistant adipocytes.
Whereas, it desensitizes the normal adipocytes and the evi-
dence to support this contention is overwhelming in various
animal cell models (17-24). To test these hypotheses directly,
we have developed a primary culture system for insulin-re-
sponsive human adipocytes from control and morbidly obese
subjects with or without NIDDM. Using this system, we de-
termined the effects of a 24-h exposure of 1 X 10-10 and 1
X 10-7 M insulin on insulin sensitivity and responsiveness of
glucose transport and insulin binding.
Methods
Materials. The carrier-free '251I-Na, 3-0-['4C]methyl-D-glucose (58.0
mCi/mmol), L-[U-'4C]leucine (300 mCi/mmol), and [U-'4C]-D-glu-
cose (260 mCi/mmol) were obtained from New England Nuclear,
Boston, MA. Crude collagenase (type I, batch 43 B 216) was obtained
from Worthington Biochemicals, Freehold, NJ. Fraction V bovine
serum albumin (BSA) was obtained from Armour Pharmaceutical Co.,
Kankakee, IL, and it was further purified by charcoal treatment (25).
Crystalline porcine insulin was kindly provided by Dr. Ronald Chance
of Eli Lilly & Co., Indianapolis, IN. All other chemicals were reagent
grade.
Human subjects. 16 morbidly obese patients with NIDDM and an
equal number of morbidly obese patients without diabetes were stud-
ied. The clinical and biochemical data ofthese patients are presented in
Table I. These patients were admitted to the hospital to undergo gastric
bypass for the treatment of morbid obesity. Nonobese-nondiabetic
subjects were used as the control group. These subjects had uncompli-
cated gallstone disease and were admitted for elective cholecystectomy,
or were patients undergoing abdominal hysterectomy. The biochemi-
cal data ofthese two clinically different subgroups ofnonobese subjects
were identical. Thus, they have been combined and referred to as the
control group. The characteristics ofthe control group were as follows:
age, 37.3±2.8 yr, sex, three male, fifteen female; weight, 65.8±2.4 kg;
height, 163±6 cm; fasting plasma glucose, 96±3 mg/dl; and fasting
plasma insulin, 12±2 ,U/ml. The mean fat cell colume was 374±30 pl.
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Table L Clinical and Biochemical Data ofObese Patients Studied
Nondiabetic NIDDM
Number 16 16
Sex
Female 14 13
Male 2 3
Age (yr) 37±4 40±2
Weight (kg) 122±5 124±5
Height (cm) 168±3 165±2
Body Fat (%) 48±1 49±1
Adipocytes volume (pl)* 789±45 80 1±74
Fasting glucose (mg/dl) 94±4 208±16§
Rate of glucose* 1.2±0.1 0.5±1§
disappearance
(%/min)
Fasting insulin (gU/ml) 35±5 39±5
Duration of obesity (yr) 17±4 20±4
Duration of diabetes (yr) 3.0±0.7
Treatment of diabetes Insulin (5)
(No. of patients) Sulfonylureas (6)
None (5)
* Mean values from eight subjects.
At er intravenous GTT (25 g).
§ P < 0.01.
With the exception of the obesity and NIDDM, none of the subjects
studied had any diseases or had taken any medications known to alter
carbohydrate metabolism.
All subjects had maintained constant body weight during the
months preceding admission. Records of food intake of the morbidly
obese patients demonstrate that 15% of the calories were derived
from proteins, 39% from fat, and 49% from carbohydrates, which is the
typical distribution of calories for this population of patients in North
Carolina (26). Because of the effect that the caloric intake and its
distribution might have on this study, morbidly obese patients studied
were admitted into the hospital 4 d before surgery. During this period,
they remained active at approximately their prehospital exercise level.
They received a weight-maintaining diet providing 50% of the calories
as carbohydrates, 30% as fat (polyunsaturated/saturated fat ratio of0.4
and cholesterol content of 600 mg), and 20% as protein. This diet was
basically the same as the one that the patients were consuming as
outpatients.
Every morbidly obese patient without known diabetes mellitus had
a 75-g oral glucose tolerance test (GTT) as an outpatient. Their carbo-
hydrate intake was > 150 g daily for the preceding 3 d before the test.
The criteria of the National Diabetes Data Group (27) was used to
classify these patients as nondiabetics. Oral glucose tolerance tests were
not performed in the morbidly obese patients with diabetes with the
exception of one who was not known to have NIDDM, but had a
fasting plasma glucose of 282 mg/dl and a peak glucose of 429 mg/dl
during the test. The morbidly obese subjects with or without NIDDM
had a 25-g intravenous GTT as outpatients to determine the rate of
glucose disappearance of plasma glucose and insulin (28). Eight of
these subjects had the intravenous GTT repeated the 3rd d of their
hospitalization, while they were on a controlled diet as described
above. Insulin or oral hypoglycemic agents were discontinued before
admission into the hospital. Rapid-acting insulin was used only if the
preprandial plasma glucose was > 300 mg/dl. The subjects underwent
surgery after an overnight fast. General anesthesia was induced with a
short-acting barbiturate, and maintained by phentanyl and nitrous
oxide-oxygen mixture. Only saline was given intravenously before the
subcutaneous fat biopsy. After exploring the abdomen, - 10 g subcu-
taneous fat was obtained through midline incision. Informed written
consent was obtained from all patients after the nature and potential
risks of the study had been explained.
Isolation of human adipocytes. Isolated human adipocytes were
prepared by the collagenase digestion method ofRodbell (29), as modi-
fied for human adipose tissue by Pedersen et al. (30). Since in many
experiments we maintained isolated human adipocytes in primary
culture for 24 h, the entire procedure of cell isolation was performed
under strict sterile conditions. The fat biopsy was transferred from the
surgical unit to the laboratory in 3% BSA-medium 199 containing
penicillin (100 U/ml) and streptomycin (100 .g/ml). The tissue was
washed three times in sterile phosphate-buffered saline and the major-
ity of the connective tissue and blood clots were removed. The tissue
was cut into small pieces of -1 X 2mm size and suspended in 10mM
Hepes-Kreb's-Ringer bicarbonate (KRB) buffer (pH 7.4) containing
3% BSA, 5 mM glucose, and 0.5 mg/ml collagenase in plastic Erlen-
meyer flasks. The ratio of tissue and collagenase buffer was 1:2 wt/vol.
The tissue was gently digested for 45-60 min in an Orbit water bath
shaken at 150-160 cycle/min at 370C in a 95% 02/5% CO2 atmo-
sphere. After digestion, the suspension was filtered twice through nylon
mesh and washed four times with 10 mM Hepes-KRB buffer (pH 7.4)
containing 3% BSA and 5 mM glucose. The washing was performed by
allowing the cells to settle under gravity, and the buffer was removed
using a 3 1/4" spinal needle or by 5-s centrifugation at 50 rpm in a
Dynac centrifuge. The cells were finally suspended at 50% lipocrit in
the assay buffer. The adipocytes were fixed at 10% lipocrit in 10%
formalin-buffered saline for 24 h. 5-jd aliquots of fixed cells were
counted and diameter of cells was determined using a grid in the
eyepiece of the microscope. The mean cell diameter and cell volume
were calculated by computer analysis using average diameter and its
standard deviation (31). Since these data were not immediately avail-
able, the experiments were performed based on percent lipocrit of cell
suspension.
We have tested several batches of collagenase from Sigma Chemi-
cal Co., St. Louis, MO, and Worthington Biochemical Corp., Free-
hold, NJ. Collagenase (Worthington Biochemical Corp.), type I
(batch 43 B 216), gave maximally insulin-responsive adipocytes for
glucose transport. With this particular batch of collagenase (0.5
mg/ml), digestion of fat tissue was complete and the lysis, as evidenced
by the ratio of floating triglycerides and intact cell volume, was negligi-
ble (< 5%) in both control as well as fat tissue from morbidly obese
patients. No preferential breakage oflarger fat cells during the isolation
procedure seemed to occur as the ratio of mean fat cell volume be-
tween control (376±30 pl) and morbidly obese (790±54 pl) subjects
was similar to those reported by Hirsch and Batchelor (32) in the intact
adipose tissue pieces between nonobese and morbidly obese subjects.
Glucose transport in adipocytes. Glucose transport in fat cells was
measured by determining the uptake of ['4C-U]glucose at tracer con-
centrations as described by Kashiwagi and co-workers (33). These in-
vestigators have validated this method for measuring glucose transport
in comparison to 3-0-methyl glucose uptake in nondiabetic as well as
in diabetic subjects (1 1). The basal and insulin (10`0 and l0-7 M)-
stimulated glucose transport measured by two different isotopes, i.e.,
['4C-U]glucose (33) and ['4C-3-O-methyl]glucose (34) were compara-
ble in our morbidly obese subjects with or without NIDDM. The fat
cells at 20% lipocrit ( 200,000 cells/ml) were incubated with 500 nM
['4C-U]glucose in the absence and presence of varying insulin concen-
tration (1 X 10-"-10-7 M), for 1 h at 37°C in a 95% 02/5% CO2
atmosphere in 10 mM Hepes-KRB buffer (pH 7.4) containing 3%
BSA. The cells were then separated by centrifuging through silicone oil
and '4C-radioactivity associated with cells was counted.
Insulin binding in adipocytes. Insulin was radiolabeled with 1251I-Na
using chloramine T according to the method of Cuatrecasas (35). The
method for determining specific '251-insulin binding in human adipo-
cytes was essentially similar to that described by Olefsky (36). The
freshly isolated adipocytes at 20% lipocrit (- 200,000 cells/ml) were
incubated with '25I-insulin (1 X 10-10 M) in the absence and presence
of increasing concentrations of unlabeled insulin for 2 h at 220C in 10
mM Hepes-KRB buffer (pH 7.4) containing 3% BSA and 2 mM glu-
1074 Sinha et al.
cose. The cells were separated by centrifugation through silicone oil
and the radioactivity counted. The nonspecific binding was consis-
tently < 10% of the total binding and the degradation of '25I-insulin
determined by TCA precipitation was also < 10% under assay condi-
tions.
Primary culture of human adipocytes. The culture technique for
isolated human adipocytes was a modification ofthe one described for
isolated rat adipocytes (37, 38) and a recently described procedure for
human adipocytes (39) with minor modifications. After the digestion
of adipose tissue and cell isolation, collagenase was removed by wash-
ing the cells three times with 3% BSA-medium 199 containing peni-
cillin (100 U/ml) and streptomycin (100 ,ug/ml). The cells were then
suspended in the same medium in 1:10 ratio of cells and medium in
sterile polypropylene 50-ml conical tubes, loosely closed with screw
caps, and incubated at 370C for 24-48 h in a 5% C02-humidified
atmosphere.
Exposure ofprimary cultures ofadipocytes with insulin and wash-
ing procedure. The isolated adipocytes at 10% lipocrit were cultured in
the absence and presence of 1 X 10-'°- and 1 X 10-7-M insulin con-
centrations for 24 h at 370C in a 5% CO2-humidified atmosphere.
Under these incubation conditions, degradation of 1251-insulin at low
as well as high insulin concentrations was < 20% and did not appre-
ciably differ in different experimental groups. At the end of the incu-
bation period, the receptor-bound insulin was dissociated by the modi-
fied method of Marshall and Olefsky (22). The entire washing proce-
dure was carried out at 370C with prewarmed and gassed buffers. First
the cells were quickly washed with 3% BSA-medium 199, pH 7.4, and
then incubated with 3% BSA-medium 199, pH 7.0, for three 20-min
intervals at 370C. After the third incubation, the cells were washed
with glucose transport assay buffer (10 mM Hepes-KRB buffer, pH
7.4, containing 3% BSA). This washing procedure effectively removed
cell-associated insulin, and allowed the glucose transport system of
insulin-stimulated adipocytes to deactivate. The cells from the three
groups were then used to determine insulin sensitivity and responsive-
ness of glucose transport and specific '25I-insulin binding in the pres-
ence of varying insulin concentrations.
Statistical analysis. Descriptive statistics (mean±SEM) and com-
parative statistics (paired and unpaired Student's t test) were per-
formed using a computerized program (Stat View, the graphic statistics
for the MacIntosh computer).
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Figure 1. Glucose transport was determined at tracer ['4C-U]glucose
concentration (500 nM) in the absence and presence of different in-
sulin concentrations in freshly isolated adipocytes from control,
obese NGTT, and obese NIDDM subjects. (Bottom) Net glucose
transport expressed as glucose clearance rate (femtoliters per cell per
second) in the absence and presence of insulin. (Top) Percent change
above basal glucose transport in response to different insulin concen-
trations.
Results
Characterization offreshly isolated adipocytes. Basal and in-
sulin-stimulated glucose transport was compared in freshly
isolated adipocytes from nonobese-nondiabetic (control),
morbidly obese subjects with normal GTT (obese NGTT), and
morbidly obese patients with NIDDM (obese NIDDM) (Fig.
1). The basal glucose transport, expressed as glucose clearance
rate per cell, in obese NGTT and obese NIDDM subjects, was
significantly decreased when compared with that in controls (P
< 0.05). The maximal response of glucose transport at 1
X 10' M insulin was significantly lower in obese NGTT and
obese NIDDM subjects compared with that in controls. The
differences in basal and insulin-stimulated glucose transport
values between control and obese subjects were even more
pronounced when the data were expressed by unit cell surface
area or cell volume. Furthermore, the maximal response was
also significantly decreased (P < 0.05) in NIDDM subjects
when compared with age-, weight-, and sex-matched subjects
with normal GTT. When analyzed as percent change above
basal glucose transport in response to different insulin con-
centrations (Fig. 1, top), the decrease ofinsulin responsiveness
in obesity and NIDDM was also evident. Although, the 50%
effective dose (ED50) of insulin-stimulated glucose transport
was similar in control and obese subjects with normal glucose
tolerance, it was significantly higher in obese NIDDM sub-
jects. The percent specific '25l-insulin binding per 50,000 adi-
pocytes at tracer concentration was significantly lower in obese
NGTT compared with that in nonobese-nondiabetic controls
(P < 0.05), but it was not statistically different in the presence
ofincreasing concentration of unlabeled insulin (Fig. 2). How-
ever, when the data were expressed by cell surface area, the
specific 1251I-insulin binding at every insulin concentration was
significantly lower in obese subjects. Thus, insulin receptor
density was less on the cell surface of adipocytes from obese
subjects in comparison with nonobese controls. The percent
specific 125I-insulin binding at various insulin concentrations
was further decreased in obese NIDDM, even when the data is
expressed by cell number and was also significantly lower in
comparison to obese controls (Fig. 2). The data in freshly iso-
lated adipocytes from this patient population largely confirm
other studies on insulin-stimulated glucose transport and in-
sulin binding from obese patients with and without NIDDM
(3, 4, 33, 36, 40-44).
These data on glucose transport and insulin binding in
freshly isolated adipocytes from control, obese NGTT, and
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Figure 2. Competition curves of specific '25I-insulin binding in
freshly isolated adipocytes (200,000 cells/ml) from control, obese
NGTT, and obese NIDDM subjects.
obese NIDDM subjects, taken together, serve to illustrate that
the simple inverse relationship between circulating insulin
levels and insulin binding ("down-regulation"), and the pre-
diction from the insulin dose-response curves of insulin recep-
tor defect (increased ED50) or postreceptor defects (decreased
maximum velocity), may not always be valid. For example,
the basal insulin concentration in our obese patients with or
without diabetes is identical, but the glucose-stimulated insu-
lin release is markedly decreased in diabetics, yet insulin bind-
ing is decreased. Also, ED50 of insulin for glucose transport is
similar in obese NGTT patients to that in controls even
though specific 1251-insulin binding at tracer (1 X 10-10 M)
concentration is decreased in the obese patients when ex-
pressed either by cell number or by unit cell surface area.
Development of primary cultures of insulin responsive
human adipocytes. To understand the possible mechanism(s)
of insulin resistance, we have established a primary culture
system of human adipocytes in our laboratory. However, be-
fore we can use these cultures effectively, we should be able to
demonstrate that adipocytes from both control and obese pa-
tients with or without NIDDM are morphologically and bio-
chemically similar before and after culture.
We have observed that high BSA concentration in the cul-
ture medium and large surface area of cells exposed to the
medium as described in the methodology section significantly
minimize the disruption of cells during long-term incubation
periods. Exposure of adipocytes with low concentrations of
collagenase (0.5 mg/ml) during isolation procedure also con-
tributed to minimizing cell disruption during culture. The lysis
of fat cells during culture was assessed by comparing the ratio
of oil (mainly produced by breakage of fat cells) and total fat
cell volume. The lysis was < 5% oftotal cell volume in control,
obese NGTT, and obese NIDDM subjects after 24- or 48-h
culture. Fig. 3 is a histogram ofpercent distribution of fat cells
of different sizes from three obese subjects in freshly isolated,
24- and 48-h cultured adipocytes. Thus, no preferential break-
age of larger fat cells was observed at any stage during 48-h
culture. Similarly, we did not observe preferential breakage of
any particular size fat cells from control and obese NIDDM
100
Cell Diameter (Ipm)
Figure 3. Percent distribution of different size cells from obese
NGTT subjects immediately after isolation (top), after 24-h (middle),
and after 48-h (bottom) culture.
subjects. The [14C]leucine incorporation into proteins was sim-
ilar in fat cells cultured in 10% fetal bovine serum or 3% BSA
without fetal bovine serum. The ability to culture human adi-
pocytes in a chemically defined medium offers a distinct ad-
vantage over the cells cultured in fetal bovine serum in the
presence of complicating hormonal factors.
To further validate our culture system, we have compared
insulin binding and glucose transport in freshly isolated and
24-h cultured adipocytes. In control subjects, specific 1251I-in-
sulin binding at different insulin concentrations was similar in
freshly isolated or 24-h cultured adipocytes (Fig. 4, top). Al-
though the percent specific "25I-insulin binding at tracer insu-
lin concentration in 24-h cultured cells decreased slightly in
obese NGTT (Fig. 4, middle) and obese NIDDM (Fig. 4, bot-
tom) subjects, the differences were not significant. Specific
'251-insulin binding in the presence of different insulin con-
centrations was not significantly different in fresh and cultured
cells in the two obese groups. There were no significant alter-
ations in either basal or insulin-stimulated glucose transport
values in freshly isolated and 24-h cultured adipocytes from
two obese groups (Fig. 5, middle and bottom). Although no
significant differences were observed in basal or insulin-stimu-
lated glucose transport between fresh and 24-h cultured adi-
pocytes from control subjects, insulin responsiveness appeared
to slightly decrease during culture (Fig. 5, top). More impor-
tantly, the differences among the three experimental groups in
regard to stimulation of glucose transport of freshly isolated
adipocytes are well preserved even after 24-h primary culture.
Our preliminary observations of [_4C-U]glucose oxidation and
_'4C-U]glucose incorporation into triglycerides under basal
and 1 X 10-7 M insulin-stimulated conditions in freshly iso-
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Figure 4. After isolation of adipocytes, one-half of the cells were im-
mediately used for determining specific '25I-insulin binding. The re-
maining cells were cultured for 24 h in 3% BSA-medium 199,
washed with 3% BSA-lO mM Hepes-KRB buffer, pH 7.4, and spe-
cific '25I-insulin binding determined in the absence and presence of
different insulin concentrations under identical conditions as in fresh
cells.
lated and 24-h cultured adipocytes from obese NGTT and
obese NIDDM subjects, demonstrate that cultured cells also
respond to insulin for these two insulin actions (data not
shown).
Effects of24-h exposure ofinsulin on glucose transport and
'25I-insulin binding in primary cultures ofhuman adipocytes.
We investigated the possibility that insulin improves insulin
sensitivity in adipocytes from insulin-resistant states such as
NIDDM and obesity. The effects ofa 24-h insulin exposure on
basal and insulin-stimulated glucose transport in cultured adi-
pocytes from nonobese control, obese NGTT, and obese
NIDDM subjects are shown in Figs. 6, 7, and 8, respectively.
In the three study groups, basal glucose transport decreased in
cells treated for 24 h with 1 X 10-'° and 1 X l0-7 M insulin,
though the differences from buffer-treated cells were signifi-
cant only in 1 X 10-7 M insulin-treated cells (P < 0.05-0.01 for
paired t test). In the three patient groups, insulin-stimulated
glucose transport was lower in 1 X 10-'°M insulin-treated cells
in comparison with buffer-treated cells, though these differ-
ences were not significant. However, this trend in decreased
insulin-stimulated glucose transport was evident in cells
Figure 5. After isolation of adipocytes, one-half of the cells were im-
mediately used for determining basal and insulin-stimulated glucose
transport. The remaining cells were cultured for 24 h in 3% BSA-
medium 199, washed with 3% BSA-IO mM Hepes-KRB buffer, pH
7.4, and then basal and insulin-stimulated glucose transport deter-
mined.
treated with high insulin (1 X I0O- M). In controls, the percent
change above basal in the presence of different insulin con-
centrations was significantly decreased in 1 X l0-7 M insulin-
treated cells in comparison with those in buffer-treated cells (P
< 0.05, paired t test) (Fig. 6). In obese NGTT subjects, signifi-
cant reductions in glucose transport stimulated by different
concentrations of insulin in cells previously treated with 1
X lI-` M were observed for net values and percent change
above basal glucose transport (Fig. 7). Similar to nonobese and
obese subjects with normal glucose tolerance, treatment of
adipocytes from diabetic subjects with 1 X l0-I M insulin
resulted in significant reduction in net values, as well as per-
cent change above basal glucose transport in response to dif-
ferent insulin concentrations (Fig. 8). In addition to decreased
insulin responsiveness, we also observed a significant reduc-
tion in insulin sensitivity of 1 X 10-7 M insulin-treated adipo-
cytes compared with buffer-treated adipocytes from obese
NIDDM (ED5o of insulin, 3.92±0.62 vs. 1.86±0.37 X 10-10
M), obese NGTT (6.39±2.77 vs. 0.31±0.09), and control
(1.84±0.08 vs. 0.21±0.08) subjects. Our results of insulin's
effect on glucose transport clearly demonstrate that insulin
alters both insulin sensitivity and responsiveness of adipocytes
from control as well as obese and NIDDM subjects.
Utilizing these cultured adipocytes, we also investigated the
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Figure 6. Control. After isolation of the adipocytes from control sub-
jects (n = 5), the cells were divided into three equal parts and cul-
tured in 3% BSA-medium 199 for 24 h in the absence (-) and pres-
ence of 1 X 1010 M insulin (o) and 1 X io-7 M insulin (-). The cell-
associated insulin was removed by three 20-min incubations with 3%
BSA-medium 199, pH 7.0, followed by washings with 3% BSA-l0
mM Hepes-KRB buffer, pH 7.4. The basal and insulin-stimulated
glucose transport were then determined simultaneously in three
groups. (Bottom) Net glucose transport. (Top) Percent change above
basal glucose transport in response to different insulin concentrations.
effect ofinsulin on specific '251-insulin binding in the presence
of different concentrations of unlabeled insulin (Fig. 9). In all
three groups, exposure of adipocytes for 24 h with physiologi-
cal concentration of insulin (1 X 10-10 M) resulted in a - 20%
decrease in specific 1251I-insulin binding only at tracer insulin
concentration over buffer-treated cells. However, when the
cells were treated with 1 X l0-7 M insulin, the decreases in
'25I-insulin binding at tracer insulin concentration were more
pronounced. In 1 X 10-7 M insulin-treated cells, significant
reductions in specific 1251-insulin binding were also observed
with respective controls, i.e., buffer-treated cells in the pres-
ence ofdifferent concentrations ofunlabeled insulin in control
(1.6, 10, 50, and 100 ng/ml insulin), obese NGTT (1.6, 10, 50,
100, and 500 ng/ml insulin), and obese NIDDM (1.6, 10, 50,
100, and 500 ng/ml insulin) subjects. Due to the limitations of
Scathard analyses, it may be more appropriate to suggest that
insulin-induced down-regulation of insulin binding was
mainly due to decrease in receptor number in all three groups.
Discussion
To test the hypothesis that insulin induces insulin resistance in
normal cells but improves insulin sensitivity in insulin-resis-
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Figure 8. Obese NIDDM. Effect of insulin on basal and insulin-stim-
ulated glucose transport in adipocytes from obese NIDDM subjects
(n = 5) after 24-h culture in the absence (.) and presence of 1
X 10-10 M insulin (o) and 1 X 10-7 M insulin (A). The details of ex-
perimental protocol were similar to those described for Fig. 6.
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The details of the experimental protocol were similar to those de-
scribed for Fig. 6.
tant cells, we have (a) characterized a population of patients
with and without varying degrees of insulin resistance with
regards to glucose transport and insulin binding in freshly iso-
lated adipocytes; (b) developed a primary culture of human
adipocytes that maintains the same degree ofinsulin resistance
as do the freshly isolated adipocytes; and (c) tested the effects
of a 24-h exposure of physiological and high concentrations of
insulin in primary culture of adipocytes from these patient
populations.
The data in freshly isolated adipocytes from this patient
population largely confirm other studies on insulin action and
insulin binding from obese patient with and without NIDDM
(3, 4, 33, 36, 40-44). The benefits of using cultured adipocytes
and human or rat adipose tissue pieces to identify regulatory
mechanism(s) of insulin receptors and insulin action is well
established (20, 37, 38, 45-49). A report using cultured human
adipocytes from normal subjects has appeared (39). However,
insulin sensitivity and responsiveness were not established by
these investigators (39). The significance of the cell system
described in this report is twofold. First, the cultures ofhuman
adipocytes are insulin responsive with regard to glucose trans-
port and metabolism. Second, and most important, adipocytes
from normal and insulin-resistant patients maintain the origi-
nal characteristics offreshly isolated adipocytes in culture. The
24-h insulin exposure ofcultured human adipocytes decreased
insulin sensitivity and responsiveness. These decreases are
similar in control, obese NGTT, and obese NIDDM patients.
Also, the extent of down-regulation of the insulin receptor by
insulin under in vitro conditions was similar in the three
groups of patients. We have previously proposed that the regu-
lation of the cell surface insulin receptors is one of the many
biological actions of insulin (19). Thus, if a cell is resistant to
this function of insulin, the number of insulin receptors might
be normal or even high in the presence of hyperinsulinemia.
The present study demonstrates that adipocytes which are re-
sistant to insulin with regard to glucose transport are normally
responsive to the ability of insulin to down-regulate insulin
receptors. Kashiwagi et al. (33) have also demonstrated that
adipocytes from NIDDM patients which were resistant to in-
sulin with regard to glucose transport were normally respon-
sive to insulin with regard to inhibition of lipolysis.
Our study does not provide any clue as to the mechanism
ofinduced insulin resistance by prolonged exposure to insulin.
Clearly, it is not only due to insulin receptor loss. Further-
more, the recent studies by Marshall et al. (38) and Garvey et
al. (48, 49), using rat adipocytes, demonstrate that changes in
insulin action may precede any change in insulin binding. We
and others have demonstrated in cultured rat hepatocytes (50),
adipocytes (51), and hepatoma cells (52) that chronic exposure
of cells to insulin decreases the intrinsic activity of the insulin
receptor kinase. Furthermore, adipose tissue of similar mor-
bidly obese patients with NIDDM shows a defect in the insulin
receptor kinase activity (53). Thus, insulin-induced resistance
may be due to the inactivation ofthe insulin receptor kinase or
any ofthe other postinsulin binding events that are believed to
be important for the mediation of insulin action (54-57).
The different results between previously published reports
regarding the improved in vivo (6-9) and in vitro (10, 11)
sensitivity to insulin in NIDDM patients after insulin treat-
ment, and the present study demonstrating a worsening of
insulin resistance by insulin in cultured adipocytes ofNIDDM
patients, is of interest. The different duration of insulin expo-
sure could be the explanation. However, it seems appropriate
to speculate that for insulin to have a beneficial effect on insu-
lin sensitivity, the interaction with other hormones or factors
that are absent in serum-free medium may be crucial. Further-
more, it may not be insulin per se, but another factor that is
induced by insulin in NIDDM patients that may be enhancing
insulin sensitivity. Amatruda et al. (58) have previously shown
that in nonketotic streptozotocin diabetic rats administration
of insulin improved insulin action in the liver. In contrast, in
vitro insulin exposure of primary cultures of hepatocytes from
these same diabetic insulin-resistant animals did not result in
an improved insulin response (58). The factor(s) that regulate
insulin action are largely unknown. However, the cell model
described here with human cells in culture from normal and
insulin-resistant subjects should facilitate the search of the
mechanism(s) that modulate insulin action in man.
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